
Quanterix Corporation QTRX
$ 3.55
-8.97%
Annual report 2025
added 03-02-2026
Quanterix Corporation Interest Expense 2011-2026 | QTRX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 K | -136 K | 2.52 M | -62 K | 1.26 M | -49 K | -10 K | -7 K | -63 K | -164 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.52 M | -164 K | 345 K |
Quarterly Interest Expense Quanterix Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -178 K | 49 K | 61 K | - | 5 K | -9 K | 226 K | - | -154 K | 8 K | - | -101 K | -358 K | -217 K | - | -305 K | 1.98 M | -194 K | 155 K | -26 K | -11 K | -167 K | 139 K | -34 K | -68 K | -47 K | 81 K | -25 K | -48 K | 24 K | -73 K | 13 K | 77 K | 255 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.98 M | -358 K | 35.2 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Beyond Air
XAIR
|
9 K | $ 0.72 | 3.86 % | $ 48.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Xtant Medical Holdings
XTNT
|
4.16 M | $ 0.54 | -4.43 % | $ 72.2 M | ||
|
Zimmer Biomet Holdings
ZBH
|
-31.1 M | $ 88.29 | -0.97 % | $ 17.9 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 165.93 | -6.43 % | $ 12.4 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.9 | -5.43 % | $ 1.64 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.39 | 4.51 % | $ 40.1 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 104.33 | -0.23 % | $ 182 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 69.42 | -1.07 % | $ 103 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 34.68 | -5.35 % | $ 1.08 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.14 | -5.73 % | $ 3.34 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 79.45 | -3.23 % | $ 46.5 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.11 | -2.63 % | $ 1.5 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.65 | -4.31 % | $ 367 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
99 K | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
-668 K | $ 0.67 | -1.26 % | $ 28 M | ||
|
Penumbra
PEN
|
893 K | $ 335.28 | -0.34 % | $ 13 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 49.77 | -1.35 % | $ 1.46 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
1.01 M | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
926 K | - | - | $ 6.6 M |